A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients

NCT00903682 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

157

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infection
HIV
Acquired Immunodeficiency Syndrome

Interventions

DRUG: etravirine (ETR, TMC125)
DRUG: efavirenz (EFV)

Sponsor

Janssen-Cilag International NV